Infectologia

HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.

JAMA. 2025 Jul; doi: 10.1001/jama.2025.9894. pii: e259894.

Updates on the neurological manifestations of SARS-CoV-2 infection.

Current opinion in infectious diseases. 2025 Jun; 38(Jun):234-241. doi: 10.1097/QCO.0000000000001110. pii: .

Recent Advances in Immunotherapeutic and Vaccine-Based Approaches for the Treatment of Drug-Resistant Bacterial Infections.

ACS infectious diseases. 2025 Jun; 11(Jun):1366-1402. doi: 10.1021/acsinfecdis.5c00001. pii: .

Recent Advances in Diagnostics and Therapeutic Interventions for Drug-Resistant Malaria.

ACS infectious diseases. 2025 Jun; 11(Jun):1296-1332. doi: 10.1021/acsinfecdis.4c00962. pii: .

Future immunisation strategies to prevent Streptococcus pneumoniae infections in children and adults.

The Lancet. Infectious diseases. 2025 Jun; 25(Jun):e330-e344. doi: 10.1016/S1473-3099(24)00740-0. pii: S1473-3099(24)00740-0.

Corticosteroids for viral central nervous system infections.

Current opinion in infectious diseases. 2025 Jun; 38(Jun):271-279. doi: 10.1097/QCO.0000000000001106. pii: .

Mpox: emergence following smallpox eradication, ongoing outbreaks and strategies for prevention.

Current opinion in infectious diseases. 2025 Jun; 38(Jun):222-227. doi: 10.1097/QCO.0000000000001100. pii: .

Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention.

Current opinion in infectious diseases. 2025 Jun; 38(Jun):208-213. doi: 10.1097/QCO.0000000000001113. pii: .

2025: new infectious diseases and the re-emergence of vaccine-preventable infections.

Current opinion in infectious diseases. 2025 Jun; 38(Jun):199-200. doi: 10.1097/QCO.0000000000001104. pii: .

Measles 2025.

The New England journal of medicine. 2025 Jun; doi: 10.1056/NEJMra2504516. pii: .

Predictors of treatment-emergent resistance to dolutegravir.

The lancet. HIV. 2025 Jun; doi: 10.1016/S2352-3018(25)00127-4. pii: S2352-3018(25)00127-4.

An HIV Vaccine in the Era of Twice-Yearly Lenacapavir for PrEP - Essential or Irrelevant?

The New England journal of medicine. 2025 Apr; 392(Apr):1561-1563. doi: 10.1056/NEJMp2415893. pii: .

Short-course antibiotic strategies for ventilator-associated pneumonia.

Current opinion in infectious diseases. 2025 Apr; 38(Apr):182-189. doi: 10.1097/QCO.0000000000001094. pii: .

Tuberculosis molecular bacterial load assay in the management of tuberculosis.

Current opinion in infectious diseases. 2025 Apr; 38(Apr):176-181. doi: 10.1097/QCO.0000000000001084. pii: .

Respiratory infections in lung transplant recipients.

Current opinion in infectious diseases. 2025 Apr; 38(Apr):150-160. doi: 10.1097/QCO.0000000000001097. pii: .

Dermatological manifestations during Dengue, Chikungunya, and Zika infections.

Current opinion in infectious diseases. 2025 Apr; 38(Apr):92-98. doi: 10.1097/QCO.0000000000001077. pii: .

Recurrence of skin and soft tissue infections: identifying risk factors and treatment strategies.

Current opinion in infectious diseases. 2025 Apr; 38(Apr):71-77. doi: 10.1097/QCO.0000000000001096. pii: .

Global guideline for the diagnosis and management of candidiasis: an initiative of the ECMM in cooperation with ISHAM and ASM.

The Lancet. Infectious diseases. 2025 May; 25(May):e280-e293. doi: 10.1016/S1473-3099(24)00749-7. pii: S1473-3099(24)00749-7.

State of the art and the future of microbiome-based biomarkers: a multidisciplinary Delphi consensus.

The Lancet. Microbe. 2025 Feb; 6(Feb):100948. doi: 10.1016/j.lanmic.2024.07.011. pii: S2666-5247(24)00201-5.

Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel.

JAMA. 2025 Feb; 333(Feb):609-628. doi: 10.1001/jama.2024.24543. pii: .

Advancing the chemotherapy of tuberculous meningitis: a consensus view.

The Lancet. Infectious diseases. 2025 Jan; 25(Jan):e47-e58. doi: 10.1016/S1473-3099(24)00512-7. pii: S1473-3099(24)00512-7.

Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; doi: 10.1093/cid/ciae479. pii: ciae479.

Meningitis (bacterial) and meningococcal disease: recognition, diagnosis and management-summary of updated NICE guidance.

BMJ (Clinical research ed.). 2024 Nov; 387(Nov):q2452. doi: 10.1136/bmj.q2452. pii: .

Piperacillin/Tazobactam Susceptibility Test Interpretive Criteria for Enterobacterales: Recommendations From the United States Committee on Antimicrobial Susceptibility Testing.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Dec; 79(Dec):1354-1362. doi: 10.1093/cid/ciae328. pii: .

European Society of Clinical Microbiology and Infectious Diseases/European Committee on infection control clinical guidelines on pre-operative decolonization and targeted prophylaxis in patients colonized by multidrug-resistant Gram-positive bacteria before surgery.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2024 Dec; 30(Dec):1537-1550. doi: 10.1016/j.cmi.2024.07.012. pii: S1198-743X(24)00341-0.

Hepatitis C Guidance 2023 Update: AASLD-IDSA Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2023 May; doi: 10.1093/cid/ciad319. pii: ciad319.

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Risk Assessment in Adults and Children.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; 79(Oct):S88-S93. doi: 10.1093/cid/ciae347. pii: .

The inclusion of children and adolescents in tuberculosis diagnostic development and evaluation-a consensus statement.

The Lancet. Infectious diseases. 2024 Nov; 24(Nov):e688-e695. doi: 10.1016/S1473-3099(24)00339-6. pii: S1473-3099(24)00339-6.

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Diagnostic Imaging of Suspected Acute Diverticulitis in Adults and Pregnant People.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; 79(Oct):S109-S112. doi: 10.1093/cid/ciae350. pii: .

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intraabdominal Infections: Diagnostic Imaging of Suspected Acute Cholecystitis and Acute Cholangitis in Adults, Children, and Pregnant People.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; 79(Oct):S104-S108. doi: 10.1093/cid/ciae349. pii: .

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Diagnostic Imaging of Suspected Acute Appendicitis in Adults, Children, and Pregnant People.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; 79(Oct):S94-S103. doi: 10.1093/cid/ciae348. pii: .

EASL Clinical Practice Guidelines on hepatitis delta virus.

Journal of hepatology. 2023 Aug; 79(Aug):433-460. doi: 10.1016/j.jhep.2023.05.001. pii: S0168-8278(23)00317-3.

Global guideline for the diagnosis and management of cryptococcosis: an initiative of the ECMM and ISHAM in cooperation with the ASM.

The Lancet. Infectious diseases. 2024 Feb; doi: 10.1016/S1473-3099(23)00731-4. pii: S1473-3099(23)00731-4.

A Review of Antibacterial Candidates with New Modes of Action.

ACS infectious diseases. 2024 Oct; 10(Oct):3440-3474. doi: 10.1021/acsinfecdis.4c00218. pii: .

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Utility of Intra-abdominal Fluid Cultures in Adults, Children, and Pregnant People.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; 79(Oct):S123-S126. doi: 10.1093/cid/ciae353. pii: .

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Utility of Blood Cultures in Adults, Children, and Pregnant People.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; 79(Oct):S118-S122. doi: 10.1093/cid/ciae352. pii: .

2024 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Complicated Intra-abdominal Infections: Risk Assessment, Diagnostic Imaging, and Microbiological Evaluation in Adults, Children, and Pregnant People.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2024 Oct; 79(Oct):S81-S87. doi: 10.1093/cid/ciae346. pii: .

Consensus recommendations for use of long-acting antiretroviral medications in the treatment and prevention of HIV-1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists.

Pharmacotherapy. 2024 Jul; 44(Jul):494-538. doi: 10.1002/phar.2922. pii: .

Invasive Fungal Diseases in Adult Patients in Intensive Care Unit (FUNDICU): 2024 consensus definitions from ESGCIP, EFISG, ESICM, ECMM, MSGERC, ISAC, and ISHAM.

Intensive care medicine. 2024 Apr; 50(Apr):502-515. doi: 10.1007/s00134-024-07341-7. pii: .

Clinical Practice Guideline by the Pediatric Infectious Diseases Society (PIDS) and the Infectious Diseases Society of America (IDSA): 2023 Guideline on Diagnosis and Management of Acute Bacterial Arthritis in Pediatrics.

Journal of the Pediatric Infectious Diseases Society. 2024 Jan; 13(Jan):1-59. doi: 10.1093/jpids/piad089. pii: .

Infectious Diseases Society of America 2023 Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2023 Jul; doi: 10.1093/cid/ciad428. pii: ciad428.

Screening for Latent Tuberculosis Infection in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.

JAMA. 2023 May; 329(May):1495-1509. doi: 10.1001/jama.2023.3954. pii: .

HepB-CpG Vaccine in People With HIV and Prior Nonresponse to HBV Vaccine: The BEe-HIVe Trial End-of-Study Results.

JAMA. 2025 Jul; doi: 10.1001/jama.2025.9894. pii: e259894.

Cefiderocol susceptibility testing: the challenge of disc diffusion.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2025 Jul; 31(Jul):1082-1088. doi: 10.1016/j.cmi.2024.12.037. pii: S1198-743X(24)00644-X.

Measles 2025.

The New England journal of medicine. 2025 Jun; doi: 10.1056/NEJMra2504516. pii: .

Predictors of treatment-emergent resistance to dolutegravir.

The lancet. HIV. 2025 Jun; doi: 10.1016/S2352-3018(25)00127-4. pii: S2352-3018(25)00127-4.

Recent Advances in Immunotherapeutic and Vaccine-Based Approaches for the Treatment of Drug-Resistant Bacterial Infections.

ACS infectious diseases. 2025 Jun; 11(Jun):1366-1402. doi: 10.1021/acsinfecdis.5c00001. pii: .

Recent Advances in Diagnostics and Therapeutic Interventions for Drug-Resistant Malaria.

ACS infectious diseases. 2025 Jun; 11(Jun):1296-1332. doi: 10.1021/acsinfecdis.4c00962. pii: .

Natural History of Clostridioides difficile-Related Disease Progression in the 2-Step Testing Era.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025 Jun; 80(Jun):975-983. doi: 10.1093/cid/ciaf020. pii: .

Does "Toxoplasma Abscess" Properly Describe Brain Lesions Caused by Toxoplasma gondii?

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2025 Jun; 80(Jun):1171-1172. doi: 10.1093/cid/ciae463. pii: .

Lenacapavir: a first-in-class capsid inhibitor for HIV treatment and prevention.

Current opinion in infectious diseases. 2025 Jun; 38(Jun):208-213. doi: 10.1097/QCO.0000000000001113. pii: .

2025: new infectious diseases and the re-emergence of vaccine-preventable infections.

Current opinion in infectious diseases. 2025 Jun; 38(Jun):199-200. doi: 10.1097/QCO.0000000000001104. pii: .